NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1114131711 MD
Verify on CMS → Mark Pajeau, MD
Hematology & Oncology Physician in Rolla, Missouri.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 492 beneficiaries · Hematology & Oncology Physician avg: 847
MIPS score
8.3/100
▼ 75 pts below national avg 83.1 · Penalty band
Industry payments
$273.55
13 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mark Pajeau, MD reported a CMS MIPS final score of 8.3/100 - below the 83.1 national average - and filed 3,687 Medicare Part D claims in 2023.
- 8.3/100
- MIPS score · -75 vs avg
- 4K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Pajeau, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
8 2nd percentile higher than 2% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Pajeau, MD sits
This provider among hematology & oncology physician peers
Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Pajeau, MD writes more Part D claims than 99% of them and scores higher on MIPS quality than 1% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Mark Pajeau, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Pajeau, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Pajeau, MD?
Below national averagePrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
3,687 335% vs specialty avg
MIPS final score
8.3/100 74.8 pts vs avg
Specialty distribution in Missouri
How Hematology & Oncology Physician compares to other specialties among Missouri providers
Medicare quality performance, MIPS
Mark Pajeau, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 8.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) - 8.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Pajeau, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 1060 W 10TH ST, Rolla, MO, 65401, with a listed phone of (855) 406-3324. NPI 1114131711 was issued on 05/10/2007.
Medicare Part D records for calendar year 2023 show 3,687 prescription claims written by this provider, covering 492 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, with an opioid prescribing rate of 14.6%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 8.3/100 for the 2023 performance year (Quality 0, Cost 27.7), compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1114131711 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/10/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
8.3018
Final Score
Avg: 83.1
0
Quality
27.6726
Cost
0
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Pajeau, MD. Source: openpaymentsdata.cms.gov.
Total received
$274
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
3,687
Total Claims
$2.0M
Total Drug Cost
492
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,983
- Total Day Supply
- 135,993
- Generic Drug Cost
- $288K
- Opioid Claims
- 539 (14.6% rate)
- Antibiotic Claims
- 213
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 2.14
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 85, 65-74: 212, 75-84: 133, 85+: 62
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Pajeau, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisone
Prednisone
203 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
197 claims
- Oxycodone Hcl
Oxycodone Hcl
183 claims
- Letrozole
Letrozole
182 claims
- Eliquis
Eliquis
155 claims
- Alprazolam
Alprazolam
146 claims
- Gabapentin
Gabapentin
91 claims
- Anastrozole 74
Anastrozole
74 claims
| Drug | Claims |
|---|---|
| Prednisone | 203 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 197 |
| Oxycodone Hcl | 183 |
| Letrozole | 182 |
| Eliquis Apixaban | 155 |
| Alprazolam | 146 |
| Gabapentin | 91 |
| Anastrozole | 74 |
| Methylphenidate Hcl | 73 |
| Ondansetron Hcl | 73 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Mark Pajeau, MD fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Mark Pajeau, MD's 3,687 claims are above the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Pajeau.
Dr. Jamshed Agha
MD
Saint Charles, MO
Dr. Bader Alahmari
MBBS
St Louis, MO
Dr. Yaqoob Ali
M.D.
Rolla, MO
Dr. Ace Allen
M.D.
Kansas City, MO
Dr. Marci Allen
DO
Kansas City, MO
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Missouri medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Missouri
Frequently Asked Questions
What is Mark Pajeau, MD's specialty? ▼
Mark Pajeau, MD specializes in Hematology & Oncology Physician and practices in Rolla, Missouri. Credentials: MD.
How much does Mark Pajeau, MD prescribe under Medicare Part D? ▼
In 2023, Mark Pajeau, MD wrote 3,687 Medicare Part D claims totaling $2.0M in drug costs for 492 beneficiaries.
What is Mark Pajeau, MD's Medicare quality score? ▼
Mark Pajeau, MD has a CMS MIPS Final Score of 8.3/100 (Quality: 0, Cost: 27.7). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Pajeau, MD located? ▼
Mark Pajeau, MD is located at 1060 W 10TH ST, Rolla, MO, 65401. Phone: (855) 406-3324.
What is Mark Pajeau, MD's NPI number? ▼
Mark Pajeau, MD's National Provider Identifier (NPI) is 1114131711, issued on 05/10/2007.
Does Mark Pajeau, MD prescribe opioids? ▼
Yes, Mark Pajeau, MD had 539 opioid claims in 2023 with an opioid prescribing rate of 14.6%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Mark Pajeau, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Pajeau, MD's most frequently prescribed drugs include Prednisone, Hydrocodone-Acetaminophen, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Pajeau, MD accept Medicare? ▼
Mark Pajeau, MD appears in CMS Medicare data with 3,687 Part D claims and 492 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Pajeau, MD's credentials? ▼
Mark Pajeau, MD's NPI is 1114131711 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.